Earnings Call · Q2 FY2025·2025-08-08

Q2 25EPS +23.61%·Rev n/aQ1 25EPS +5.08%·Rev n/aQ4 24EPS -100.00%*·Rev n/aQ3 24EPS +67.47%·Rev n/a⚠ consensus missing

Ginkgo Bioworks Holdings, Inc. DNA

Daniel Waid Marshall — Senior Manager of Communications and Ownership

Jason Kelly — Co-Founder and Chief Executive Officer

Steven P. Coen — Chief Financial Officer

−8.7%1d on move date−9.5% vs SPY3d−14.1%5d−4.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more DNA calls or request research access.

More DNA calls Browse calls Request research access